In light of our findings, ESM1 appears to be a key regulator of thyroid cancer cell biology and could be an invaluable addition to the therapeutic arsenal against PTC, potentially improving patient outcomes and quality of life. This evidence concerns the gene ESM1 and thyroid cancer.